Monday 19 November 2018
Home      All news      Contact us      Philipino
Channel News Asia - 1 month ago

Sanofi drug Dupixent wins FDA approval to treat asthma

REUTERS: France s Sanofi SA said on Friday eczema drug Dupixent was approved by the U.S. Food and Drug Administration as an additional maintenance therapy in patients with two types of asthma. Dupixent, co-developed with U.S.-based Regeneron, received approval to treat patients with eosinophilic ...

Related news

Latest News
Hashtags:   

Sanofi

 | 

Dupixent

 | 

approval

 | 

treat

 | 

asthma

 | 
Most Popular (6 hours)

Most Popular (24 hours)

Most Popular (a week)

Sources